Lunai Bioworks Profit Margin

Lunai Bioworks (LNAI) currently reports a profit margin of -6125.68% as of March 2026. That compares with -557.7% in the prior-year period — down 998.4% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Lunai Bioworks's profit margin history and peer comparisons.

Lunai Bioworks's profit margin decreased from -557.7% to -6125.68% — a 998.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lunai Bioworks's profit margin of -6125.68% is lower than the Healthcare sector average of 15.58%. That is roughly 3930842.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Lunai Bioworks's current -6125.68% should be judged against Healthcare norms (sector average: 15.58%) and against LNAI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -6125.68%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Lunai Bioworks, and consider following LNAI for alerts when major investors trade the stock.